Practical use of GenoType® HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 4, 2011, Pages 557-560

  Miendje Deyi, Véronique Yvette ^a   Burette, Alain ^b   Bentatou, Zahra ^c   Maaroufi, Younes ^d   Bontems, Patrick ^e   Lepage, Philippe ^e   Reynders, Marijke ^f  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b Centre Hospitalier interregional Edith Cavell   (Belgium)

^c Cliniques de l'Europe   (Belgium)

^d SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^e HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^f AZ Sint Jan Brugge Oostende AV   (Belgium)

Author keywords

Antimicrobials resistance; Clarithromycin fluoroquinolones; Diagnosis; Helicobacter pylori; Molecular method

Indexed keywords

CLARITHROMYCIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 28S;

ADOLESCENT; ADULT; AGED; ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM DETECTION; CHILD; CONTROLLED STUDY; CULTURE TECHNIQUE; FEMALE; GENOTYPE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR GENETICS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79960355798     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.05.002     Document Type: Article

References (15)

1. Bogaerts P., Berhin C., Nizet H., Glupczynski Y. Prevalence and mechanisms of resistance to fluoroquinolones in H. pylori strains from patients living in Belgium. Helicobacter 2006, 11:441-445.
2. Boyanova L., Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev. Anti. Infect. Ther. 2010, 8:59-70.
3. Cambau E., Allerheiligen V., Coulon C., Corbel C., Lascols C., Deforges L., Soussy C.J., Delchier J.C., Megraud F. Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J. Clin. Microbiol. 2009, 47:3600-3607.
4. Chey W.D., Wong B.C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007, 102:1808-1825.
5. Kusters J.G., Gerrits M.M., Van Strijp J.A., Vandenbroucke-Grauls C.M. Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect. Immun. 1997, 65:3672-3679.
6. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E.J. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-781.
7. Mégraud F., Lehours P.h. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 2007, 20:280-322.
8. Miendje Deyi V.Y., Bontems P., Vanderpas J., De Koster E., Ntounda R., Van den Borre C., Cadranel S., Burette A. Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium. J. Clin. Microbiol. 2011, 49:2200-2209.
9. Miendje Deyi V.Y., Vanderpas J., Bontems P., VAN DEN Borre C., De Koster E., Cadranel S., Burette A. Marching cohort of Helicobacter pylori infection over two decades (1988-2007): combined effects of secular trend and population migration. Epidemiol. Infect. 2011, 139:572-580.
10. Miendje Deyi V.Y., Van den Borre C., Fontaine V. Comparative evaluation of 3 selective media for primary isolation of Helicobacter pylori from gastric biopsies under routine conditions. Diagn. Microbiol. Infect. Dis. 2010, 68:474-476.
11. Performance standards for antimicrobial susceptibility testing and approved standard M7-A5. Informational supplement M100-S10 2000, National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Owen R.J. Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 2002, 50:285-289.
13. Raymond J., Lamarque D., Kalach N., Chaussade S., Burucoa C. High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter 2010, 15:21-27.
14. vanDoorn L.J., Glupczynski Y., Kusters J.G., Megraud F., Midolo P., Maggi-Solca N., Queiroz D.M., Nouhan N., Stet E., Quint W.G. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob. Agents Chemother. 2001, 45:1500-1504.
15. Wu J.Y., Kim J.J., Reddy R., Wang W.M., Graham D.Y., Kwon D.H. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob. Agents Chemother. 2005, 49:578-583.